Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Bruce R. Basson, MS
JCP
Letter to the Editor
Is There a Real Difference Between the First Onset of Efficacy for Atypical Antipsychotic Monotherapies in Acute Bipolar Mania?
October 14, 2005
Tamás Treuer
,
Bruce R. Basson
JCP
Original Research
Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone
April 1, 2001
Bruce R. Basson
,
Bruce J. Kinon
,
Cindy C. Taylor
, et al
JCP
Original Research
Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia
February 2, 2001
Bruce J. Kinon
,
Bruce R. Basson
,
Julie A. Gilmore
, et al
JCP
Article
Weight Change and Atypical Antipsychotic Treatment in Patients With Schizophrenia
February 1, 2001
Barry Jones
,
Bruce R. Basson
,
Daniel J. Walker
, et al
JCP
Original Research
Strategies for Switching From Conventional Antipsychotic Drugs or Risperidone to Olanzapine
October 31, 2000
Bruce J. Kinon
,
Bruce R. Basson
,
Julie A. Gilmore
, et al
PCC
Original Research
The Comparative Peripheral Anticholinergic-Like Adverse Event Profiles of Olanzapine and Risperidone
August 1, 2000
John S. Kennedy
,
Frank P. Bymaster
,
Bruce R. Basson
, et al